Live Breaking News & Updates on Jamie Christensen

Stay updated with breaking news from Jamie christensen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inceptionr LLC Buys New Position in Mirati Therapeutics, Inc. (NASDAQ:MRTX)

Inceptionr LLC Buys New Position in Mirati Therapeutics, Inc. (NASDAQ:MRTX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Stifel Nicolaus , Jamie Christensen , Jefferies Financial Group , Securities Exchange Commission , Us Bancorp , Mirati Therapeutics Inc , Quent Capital , Advisor Group Holdings Inc , Headlands Technologies , Mirati Therapeutics , Free Report , Group Holdings , Financial Advisors , Exchange Commission , Get Free Report , Financial Group , Visit Holdingschannel , Mirati Therapeutics Daily ,

Mirati Therapeutics (NASDAQ:MRTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a report published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other research firms also recently commented on MRTX. SVB Leerink reaffirmed a market perform rating and issued a $58.00 target price (down previously […] ....

United States , Jamie Christensen , Piper Sandler , Goldman Sachs Group Inc , Securities Exchange Commission , Mirati Therapeutics Inc , Mirati Therapeutics Company Profile , Mirati Therapeutics , Free Report , Get Free Report , Exchange Commission , Sachs Group , Capital Partners , Mirati Therapeutics Daily , Nasdaq Mrtx , Initiated Coverage , Stocknews Com ,

Mirati Therapeutics (NASDAQ:MRTX) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research note released on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Several other research firms have also commented on MRTX. Morgan Stanley lowered their price target on shares of Mirati Therapeutics from $42.00 to $37.00 and […] ....

United States , Piper Sandler , Jamie Christensen , Bluepath Capital Management , Acadian Asset Management , First Horizon Advisors Inc , Morgan Stanley , Quent Capital , Mirati Therapeutics Inc , Mirati Therapeutics , Free Report , Therapeutics Trading Down , Get Free Report , Horizon Advisors , Asset Management , Mirati Therapeutics Daily , Nasdaq Mrtx , Initiated Coverage , Stocknews Com ,

Mirati Therapeutics, Inc. (NASDAQ:MRTX) Given Consensus Recommendation of "Hold" by Brokerages

Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) has been assigned an average recommendation of “Hold” from the sixteen brokerages that are currently covering the company, MarketBeat Ratings reports. Twelve investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price […] ....

United States , Jamie Christensen , Securities Exchange Commission , Jefferies Financial Group , Morgan Stanley , Acadian Asset Management , Metlife Investment Management , Mirati Therapeutics Company Profile , Blackrock Inc , Mirati Therapeutics Inc , Advisor Group Holdings Inc , Us Bancorp , Mirati Therapeutics , Get Free Report , Marketbeat Ratings , Financial Group , Therapeutics Trading Down , Exchange Commission , Group Holdings , Asset Management , Life Investment Management , Get Free , Mirati Therapeutics Daily , Nasdaq Mrtx ,

Mirati Therapeutics (NASDAQ:MRTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a report published on Saturday morning. The brokerage issued a sell rating on the biotechnology company’s stock. MRTX has been the topic of several other reports. Bank of America reduced their target price on Mirati Therapeutics from $54.00 to $46.00 in a […] ....

United States , Jamie Christensen , Piper Sandler , Mirati Therapeutics Company Profile , Us Bancorp , Mirati Therapeutics Inc , Sg Americas Securities , Headlands Technologies , Connor Clark Lunn Investment Management Ltd , Securities Exchange Commission , Mirati Therapeutics , Free Report , Get Free Report , Exchange Commission , Lunn Investment Management , Mirati Therapeutics Daily , Nasdaq Mrtx , Initiated Coverage , Stocknews Com ,